Infographic: AAV characterization: the what, why and how

This infographic maps the complete AAV development journey from the initial discovery of disease-causing genetic mutations to the final characterization of therapeutic vectors for clinical use. Explore how cutting-edge analytical platforms identify therapeutic targets, how specialized cell lines are engineered to produce high-quality AAV particles, and why rigorous purification and characterization steps are essential for patient safety.

[Illustrated by Tobias Dumbraveanu]

In association with: